Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
Heart failure is a major global health concern. Noncoding RNAs (ncRNAs) are involved in physiological processes and in the pathogenesis of various diseases, including heart failure. ncRNAs have emerged as critical components of transcriptional regulatory pathways that govern cardiac development, str...
Main Authors: | Peilei Lu, Fan Ding, Yang Kevin Xiang, Liying Hao, Meimi Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/5/777 |
Similar Items
-
Ferroptosis in cardiac hypertrophy and heart failure
by: Kuo Zhang, et al.
Published: (2023-12-01) -
Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
by: Ming-Yun Ho, et al.
Published: (2021-08-01) -
Roles of histone acetylation sites in cardiac hypertrophy and heart failure
by: Masafumi Funamoto, et al.
Published: (2023-03-01) -
SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury
by: Xiaoyan Yang, et al.
Published: (2023-09-01) -
Identification of Lactate as a Cardiac Protectant by Inhibiting Inflammation and Cardiac Hypertrophy Using a Zebrafish Acute Heart Failure Model
by: Elijah R. Haege, et al.
Published: (2021-03-01)